SynthesisJournal of ovarian research2022
The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis.
Chunmei Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it